NEUROENDOCRINE TUMOR
Clinical trials for NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy trial offers hope for advanced cancer patients out of options
Disease control OngoingThis study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for slowing advanced neuroendocrine tumors in major trial
Disease control OngoingThis study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Major cancer trial tests new drug duos for rare, aggressive tumors
Disease control OngoingThis large Phase 3 trial aims to find the better treatment combination for patients with advanced, high-risk neuroendocrine tumors (like carcinoid tumors) that have spread. Researchers are comparing a standard drug (octreotide) paired with either interferon or bevacizumab to see …
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Blood test registry aims to predict Cancer's return
Knowledge-focused ENROLLING_BY_INVITATIONThis study is creating a registry to collect information and blood samples from 400 people with neuroendocrine tumors. The main goal is to see how well a specific blood test, called NETest, can help doctors detect the cancer early, monitor if it comes back, and predict how patien…
Matched conditions: NEUROENDOCRINE TUMOR
Sponsor: Wren Laboratories LLC • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC